Non-epithelial endothelin-A receptors activate adenylate cyclase in rat trachea: Biochemical mechanisms and physiological implications

被引:4
作者
ElMowafy, AM
AbouMohamed, GA
机构
[1] Dept. of Pharmacol. and Biochemistry, Faculty of Pharmacy, Mansoura University, 35516, Mansoura
关键词
endothelin receptors; endothelin-A antagonists; cAMP; cyclooxygenase inhibitors; airway epithelium; trachea;
D O I
10.1016/S0024-3205(97)00712-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In the present study, we investigated the mechanisms underlying the differential effects of endothelins (ETs) in the rat trachea. Sarafotoxin-S6c (SRTX-c) and ET-3 were more potent spasmogens to rat tracheal strips than ET-1. The EC50 values were 12, 14.1 and 89.1 nM, respectively. Tension responses to ET-1 and ET-3, but not to SRTX-c, were enhanced by either indomethacin or the ETA blocker, BQ-610 (1 mu M). in epithetium-intact tracheal rings, both ET-1 and ET-3 activated adenylate cyclase (AC) in a concentration-dependent manner. The activation by ET-1 of AC was significantly higher than that of ET-3. Thus, EC50 values for ET-1 and ET-3 were 71 and 200 nM, and maximal cAMP increments were 196% and 82% above baseline, respectively. SRTX-c, up to 1 mu M, did not after basal cAMP lever. Mechanical removal of the epithelium neither had an effect on AC activation by ET-1 or ET-3, nor did it alter the inability of SRTX-c to modulate AC activity. Conversely, pre-incubation of tracheal strips with indomethacin (1 mu M) virtually ablated the increments in cAMP by the ETs. Likewise, BQ-610 attenuated AC activation, concentration-dependently (IC50 = 28.2 nM). Taken together, the present study suggests that ETA receptors, from nonepithelial source, are functionally-linked to AC activation via a prostanoid-dependent pathway. This ETA-initiated cascade acts to negatively regulate muscle contraction. Such a cross-talk between ET signals most likely accounts for variation of tension responses to ET homologs.
引用
收藏
页码:1529 / 1538
页数:10
相关论文
共 55 条
[31]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[32]   PHYSIOLOGY AND PHARMACOLOGY OF ENDOTHELINS [J].
MASAKI, T ;
YANAGISAWA, M ;
GOTO, K .
MEDICINAL RESEARCH REVIEWS, 1992, 12 (04) :391-421
[33]   2 DIFFERENT FORMS OF ENDOTHELIN RECEPTORS IN RAT LUNG [J].
MASUDA, Y ;
MIYAZAKI, H ;
KONDOH, M ;
WATANABE, H ;
YANAGISAWA, M ;
MASAKI, T ;
MURAKAMI, K .
FEBS LETTERS, 1989, 257 (02) :208-210
[34]   SPECIFIC BINDING OF ENDOTHELIN ON HUMAN BRONCHIAL SMOOTH-MUSCLE CELLS IN CULTURE AND SECRETION OF ENDOTHELIN-LIKE MATERIAL FROM BRONCHIAL EPITHELIAL-CELLS [J].
MATTOLI, S ;
MEZZETTI, M ;
RIVA, G ;
ALLEGRA, L ;
FASOLI, A .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (02) :145-151
[35]   THE MECHANISM OF ACTION OF ENDOTHELIN IN HUMAN LUNG [J].
MCKAY, KO ;
BLACK, JL ;
ARMOUR, CL .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (02) :422-428
[36]   ENDOTHELIN-3 STIMULATES LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) SECRETION FROM LHRH NEURONS BY A PROSTAGLANDIN-DEPENDENT MECHANISM [J].
MORETTO, M ;
LOPEZ, FJ ;
NEGROVILAR, A .
ENDOCRINOLOGY, 1993, 132 (02) :789-794
[37]   SPECIFIC BINDING OF ENDOTHELIN-1 TO CANINE TRACHEAL EPITHELIAL-CELLS IN CULTURE [J].
NINOMIYA, H ;
YU, XY ;
UCHIDA, Y ;
HASEGAWA, S ;
SPANNHAKE, EW .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (03) :L424-L431
[38]   ENDOTHELIN STIMULATES BOTH CAMP FORMATION AND PHOSPHATIDYLINOSITOL HYDROLYSIS IN CULTURED EMBRYONIC BOVINE TRACHEAL CELLS [J].
ODA, K ;
FUJITANI, Y ;
WATAKABE, T ;
INUI, T ;
OKADA, T ;
URADE, Y ;
OKUDAASHITAKA, E ;
ITO, S .
FEBS LETTERS, 1992, 299 (02) :187-191
[39]   Effects of endothelin receptor selective antagonists, BQ-123 and BQ-788, on IRL 1620 and endothelin-1 responses of airway and vascular preparations from rats [J].
ODonnell, SR ;
Kay, CS .
PULMONARY PHARMACOLOGY, 1995, 8 (01) :11-19
[40]   THE IMPORTANCE OF TACHYPHYLAXIS AND RELEASE OF CYCLOOXYGENASE PRODUCTS IN THE MODULATION OF ENDOTHELIN-1 INDUCED RESPONSES IN RAT AND GUINEA-PIG TRACHEAL CHAINS [J].
PEACHEY, JA ;
KITCHEN, I .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 :S190-S193